This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR
       Search

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

EPA/SWER RIN: 2050-AG39 Publication ID: Spring 2010 
Title: Amendment to the Universal Waste Rule: Addition of Pharmaceuticals 
Abstract: On December 2, 2008, EPA proposed to add hazardous pharmaceutical wastes to the federal universal waste program. The universal waste regulations streamline the collection requirements for specified hazardous wastes over current Resource Conservation and Recovery Act (RCRA) hazardous waste requirements. Even if included under the universal waste program, pharmaceutical universal wastes will still need to be sent to destination facilities that must comply with the applicable requirements for treatment, storage and disposal facilities under the full hazardous waste regulations. Finally, because this rule is less stringent than current RCRA hazardous waste regulations, authorized states are not required to modify their programs to adopt this regulation, if finalized. Therefore, the regulated entities that could opt-in to the universal waste regime include those in authorized states that have adopted the universal waste rule and amended their programs to include hazardous pharmaceutical wastes. 
Agency: Environmental Protection Agency(EPA)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 40 CFR 260; 40 CFR 261; 40 CFR 264; 40 CFR 265; 40 CFR 268; 40 CFR 270; 40 CFR 273 
Legal Authority: 42 USC 6912(a); 42 USC 6921; 42 USC 6922; 42 USC 6923; 42 USC 6924; 42 USC 6926; 42 USC 6927; 42 USC 6930; 42 USC 6937 
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  12/02/2008  73 FR 73520 
NPRM Comment Period End  02/02/2008   
Extension of Comment Period  01/30/2009  74 FR 5633 
Comment Period End  03/04/2009   
Final Action  04/00/2011   
Additional Information: SAN No. 5127; EPA publication information: NPRM - http://edocket.access.gpo.gov/2008/E8-28161.htm; Docket for proposed rule: http://www.regulations.gov/fdmspublic/component/main?main=DocketDetail&d=EPA-HQ-RCRA-2007-0932; EPA Docket information: EPA-HQ-RCRA-2007-0932.
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Federal, Local, State 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: www.epa.gov/wastes/hazard/wastetypes/universal/pharm.htm  
RIN Data Printed in the FR: No 
Agency Contact:
Lisa Lauer
Environmental Protection Agency
Solid Waste and Emergency Response
5304P,
Washington, DC 20460
Phone:703 308-7418
Fax:703 308-0514
Email: Lauer.Lisa@epa.gov

Mark Seltzer
Environmental Protection Agency
Solid Waste and Emergency Response
5304P,
Washington, DC 20460
Phone:703 347-8955
Fax:703 308-0514
Email: seltzer.mark@epa.gov

 
About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us